Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Novel compounds synthesized at SmithKline Beecham act at several 5-HT receptor subtypes

Jan. 4, 1999

New treatment for AIDS-related pain progresses to clinical testing

Jan. 4, 1999

Novo Nordisk describes novel muscarinic cholinergic receptor modulators

Dec. 30, 1998

First U.S. marketing approval for Cephalon: Provigil cleared for narcolepsy-associated EDS

Dec. 29, 1998

YM-872: neuroprotective effects in animal model indicate potential in acute ischemic stroke

Dec. 29, 1998

Peripheral nerve regeneration enhanced by hyaluronic acid in rat model

Dec. 29, 1998

More CRF antagonists emerge from Janssen/Neurocrine Biosciences collaboration

Dec. 29, 1998

Guilford patents NAALADase inhibitors for glutamate abnormalities, prostate conditions

Dec. 28, 1998

Revolutionary drugs for Alzheimer's ready for human testing described by Nymox

Dec. 28, 1998

Agents for epilepsy, stroke and brain, spinal cord trauma in development at Novartis

Dec. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...